NewsRx

Search our medical news database

Alagille Syndrome News and Articles

Return to Library

NewsRx Bundle

A quick and inexpensive way to view the most recent articles for a one-time project.

Custom Reports on Alagille Syndrome

Tired of prepackaged reports that just don't meet your needs? Target your needs!

What is Alagille syndrome?

Alagille syndrome is a genetic disorder that can affect the liver, heart, and other systems of the body.

Signs and symptoms arising from liver damage in Alagille syndrome may include a yellowish tinge in the skin and the whites of the eyes (jaundice), itching, and deposits of cholesterol in the skin (xanthomas). A liver biopsy may indicate too few bile ducts (bile duct paucity). These ducts carry bile (which helps to digest fats) from the liver to the gallbladder and small intestine.

Heart problems associated with Alagille syndrome may include impaired blood flow from the heart into the lungs for oxygenation (pulmonic stenosis). This defect may be combined with a hole between the two lower chambers of the heart (ventricular septal defect) and other problems in a condition called tetralogy of Fallot.

Facial features characteristic of Alagille syndrome include a broad, prominent forehead, deep-set eyes, and a small pointed chin. The disorder may also affect the kidneys and central nervous system, and cause an unusual butterfly shape of the bones of the spinal column that can be seen in an x-ray.

Problems associated with Alagille syndrome generally become evident in infancy or early childhood. The severity of the disorder, however, can vary within the same family, with symptoms ranging from so mild as to go unnoticed to severe heart and/or liver disease requiring transplantation.

Some people with Alagille syndrome may have only isolated signs of the disorder, such as characteristic facial features or heart defects. These individuals do not have liver disease or other features typical of the disorder.

How common is Alagille syndrome?

The estimated prevalence of Alagille syndrome is 1 in every 70,000 people. This figure is based on diagnoses of liver disease in infancy, and may be an underestimation due to the varying severity and symptoms of the disorder. The prevalence of this disorder could be as high as 1 in 20,000 people if the frequency of gene mutations that cause Alagille syndrome is considered.

What genes are related to Alagille syndrome?

Mutations in the JAG1 and NOTCH2 genes cause Alagille syndrome.

The JAG1 and NOTCH2 genes provide instructions for making proteins that fit together to trigger signaling between neighboring cells during embryonic development. This signaling influences how the cells are used to build body structures in the developing embryo. Mutations in either the JAG1 gene or NOTCH2 gene probably disrupt the signaling pathway. As a result, errors may occur during development, especially affecting the heart, bile ducts in the liver, spinal column, and certain facial features.

Narrowed and malformed bile ducts in the liver produce many of the health problems associated with Alagille syndrome. In this disorder, bile builds up in the liver and causes scarring that prevents the liver from working properly to eliminate wastes from the bloodstream.

How do people inherit Alagille syndrome?

This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

In approximately 30 percent to 50 percent of cases, an affected person inherits the mutation from one affected parent. Other cases result from new mutations in the gene. These cases occur in people with no history of the disorder in their family.

Source: National Institutes of Health

Recent Alagille Syndrome News and Articles


New Alagille Syndrome Findings from Jichi Medical University Published

2012 OCT 29 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Data detailed on Cardiovascular Diseases and Conditions have been presented. According to news reporting out of Tochigi, Japan, by NewsRx editors, research stated, "We report the first case in the literature of chorioretinal atrophy involving the macula in an 11-year-old girl with Alagille syndrome, as examined by optical coherence tomography, and fundus autofluorescence imaging. Funduscopy revealed diffuse choroidal hypopigmentation with increased visibility of the choroidal vessels and symmetric, well circumscribed macular discoloration."

Our news journalists obtained a quote from the research from Jichi Medical University, "Anomalous oblique configuration of the optic disc and peripapillary tortuous vessels were also detected. Optical coherence tomography demonstrated decreased retinal thickness, especially the outer retinal layer, and the photoreceptor inner segment/outer segment junctions were irregular and discontinued, corresponding to macular discoloration. Fundus autofluorescence imaging clearly defined hypofluorescent areas in the peripapillary regions that extended along the macula and had a sleep mask appearance."

According to the news editors, the research concluded: "We suggest that transient hypovitaminosis due to Alagille syndrome early in life might contribute to the retinal degeneration seen in this case."

For more information on this research see: Optical coherence tomography and fundus autofluorescence imaging study of chorioretinal atrophy involving the macula in Alagille syndrome. Clinical Ophthalmology, 2012;6():1445-8.

Our news journalists report that additional information may be obtained by contacting S. Makino, Dept. of Ophthalmology, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Keywords for this news article include: Asia, Japan, Tochigi, Liver Diseases, Alagille Syndrome, Bile Duct Diseases, Imaging Technology, Biliary Tract Diseases, Inborn Genetic Diseases, Congenital Abnormalities, Congenital Heart Defects, Intrahepatic Cholestasis, Digestive System Diseases, Cardiovascular Abnormalities, Optical Coherence Tomography.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook